🟢 Alzamend Neuro is trading 7.75% up today with no verified company-specific catalyst

Alzamend Neuro is trading at $1.39, up 7.75%, on October 21, 2026; no verified company-specific announcement explaining the move was found.

• XBI was reported up 2.10% during the regular session. Biotech-sector strength may be contributing, but a direct cause has not been established.
• The company’s investor-relations news page lists earlier updates, not an October 21 catalyst.
• Intraday volume information was unavailable.